Skip to content

Author

Mian Umair Ahsan

We have 4 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Preprint Oct 2026

FaceKit: a Toolkit for Interpretable Facial Phenotyping, Synthetic Image Generation and Privacy Analysis in Rare Diseases

Many rare genetic diseases are associated with recognizable craniofacial features. However, traditional approaches for describing facial morphology rely largely on qualitative clinical observation and free-text descriptions, which are often subjective, non-standardized, and difficult to reproduce across observers and i...

Hong-Zhuo Chen, Zhanliang Wang, Florent Pollet et al. · 0 citations
Open access Sep 2026

Characterization of Large-Scale Mitochondrial DNA Rearrangements Using Complementary Short- and Long-Read Sequencing Approaches

Background: Large-scale mitochondrial DNA (mtDNA) rearrangement, including deletion or duplication, is one of the important causes of primary mitochondrial disease. In clinical practice, short-read sequencing (SRS)-based assays typically detect these rearrangements by identifying regional mtDNA copy-number changes but...

Jing Wang, Joe Chan, Mian Umair Ahsan et al. · 0 citations
Open access Sep 2026

Long-read based detection of large copy number variants with potential functional significance using the ContextSV structural variant caller

ContextSV, a framework that integrates alignment evidence with copy number predictions derived from sequencing coverage and single-nucleotide variant allele frequencies to improve SV detection, serves as a valuable complement to existing long-read SV detection approaches by improving sensitivity for large and clinicall...

J. E. Perdomo, Mian Umair Ahsan, Jasmine Akoto et al. · 0 citations
Review Open access Jul 2026

RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases.

A machine learning algorithm called RankVar is developed to prioritize causative variants for rare diseases, based on clinical notes and genome/exome sequencing profiles, and may provide a useful framework for prioritizing variants in monogenic or oligogenic diseases.

Yuan Zhang, Mian Umair Ahsan, Peng Wang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.